Amgen announced that the U.S. Food and Drug Administration (FDA) has approved the Repatha® (evolocumab) Pushtronex™ system (on-body infusor with prefilled cartridge), a new, monthly single-dose administration option. The Pushtronex system is a hands-free device designed to provide 420 mg of Repatha in a single dose. Repatha is a human monoclonal antibody that blocks a protein called proprotein convertase subtilisin/kexin type 9 (PCSK9), which inhibits the body's natural system for eliminating "bad" cholesterol (low-density lipoprotein cholesterol or LDL-C) from the blood. Repatha is the first and only PCSK9 inhibitor to offer a monthly single-dose delivery option.

12 July 2016
Medzome looking for Quality Control Officer

We are a dedicated team of globally experienced scientists and bring together the right balance of research & development with best business practices to deliver the superior rapid diagnostic kits. We are committed to maintain the excellence of all our finished products. Further, we assure in formulating the material of highest caliber and guarantee the quality of each lot we create. To achieve the mission, we have embraced strategies to deliver Quality, Growth, Services cost-effectively.

This is a new diagnostic product manufacturing company at Baddi, Himachal Pradesh

Post : QC, One

12 July 2016
Opportunity for Drug Data Analyst at CareOnGo | B.Pharm, M.Pharm

CareOnGo is a mobile marketplace for ordering medicines/ health products online. We help customers deliver and understand their medication, find substitutes, get diet chart, maintain health records, and get medicine reminders. We are a sure shot destination for your medicine needs. Pharmacy market in India and across the world (Especially emerging markets). CareOnGo aspires to make medicine buying as easy and straightforward as Amazon makes buying books.
We are a young, passionate team working on a tough but huge opportunity. We believe there is the immense value (akin to serendipity) in connecting customers and sellers looking for each other. In the process, we hope to impact the lives of thousands of Retail entrepreneurs, helping them refocus on their craft.

Post: Drug Data Analyst

12 July 2016
Walk in interview for M.Tech / M.Sc / M.Pharm as Research Fellow at Indian Institute of Technology

The Institute of Chemical Technology (ICT) Mumbai was established as the Department of Chemical Technology on 1st October, 1933 by the University of Mumbai, through active support of industries and philanthropists. The Institute was most popularly known as UDCT, Mumbai. Research has been an integral part of ICT since its inception and it has created over 500 first generation entrepreneurs. The UDCT grew significantly in stature and was granted autonomy under UGC regulations by the University of Mumbai and further converted in to an Institute on 26th January, 2002. Under the World Bank TEQIP programme, the Maharashtra government granted it full autonomy in June 2004. Due to the recommendations of the Government of Maharashtra and University of Mumbai, the ICT was granted Deemed University Status by the MHRD on 12th September, 2008, with all provisions of the UGC for funding and support as the state owned deemed university.

FOR RESEARCH FELLOW ON A RESEARCH PROJECT SPONSORED BY INDIAN COUNCIL OF MEDICAL RESEARCH (ICMR) Interviews for ONE Research fellow on a project sponsored by ICMR titled “Preclinical testing for safety of synthetic peptide 1 of 80kda HSA for development of antifertility vaccine” under the supervision of ProfPadma V. Devarajan

Post : RESEARCH FELLOW

12 July 2016
Vacancy for Project Fellow/ PA II at National Chemical Laboratory

Applications are invited on plain paper for filling up of positions of Project Assistant II on a purely temporary basis, in the prescribed proforma. The detail of the Sponsored Project under which engagement is proposed to be made is as under:

12 July 2016
Walk in interview for Research Associate , Project Assistant-II, JRF at CSIR-CSMCRI | 15 Posts

The Molecular Biology and Biotechnology group of MBE Division of CSIR-CSMCRI, Bhavnagar, Gujarat is actively engaged in multidisciplinary research in frontier areas of modern biology and biotechnology such as stress genomics & proteomics, transgenics, plant-microbe interactions, skin microbiome, metagenomics, marine biotechnology, adaptation biology, gene mining and translational research. We are looking for young, talented & motivated persons (M.Sc. in Plant Molecular Biology / Biotechnology / Biochemistry / Microbiology/ Botany) to work as Research Associate (3 post) and JRF/PA-II (12 post) for various ongoing projects. Further details including qualification, fellowship, age, and application format are available on institute’s website (www.csmcri.org). Interested candidates fulfilling the required qualifications are invited to appear in Walk-in-Interview on 22. 07. 2016 (9.30 a.m.) at CSIR-CSMCRI, Bhavnagar.

Post : Research Associate , Project Assistant-II, JRF

12 July 2016
Vacancy for the post of Junior research fellow under an ICMR Project in Dept. of Cytology

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage. The institute started in 1962 and Pt Jawahar Lal Nehru inaugurated the hospital now named “Nehru Hospital” on 7th July 1963. The Institute was originally under the Government of undivided Punjab. After the reorganization of the state, the administrative control of the institute passed on to the Union Territory of Chandigarh in November 1966.  The Institute became an autonomous body under the Act of Parliament in 1967 functioning under the Ministry of Health and Family Welfare, Government of India, with the following mandate.

Applications are invited for a purely temporary posts mentioned as under for an ICMR project "Screening of endometrioid type of endometrial carcinoma for its biological markers on tissue microarray" at a fixed monthly salary as under.

Cipla Ltd announced this week that its proposed biotech subsidiary in South Africa will invest just over R1.3 billion into the country's first state-of-the-art biotech manufacturing facility, for the production of biosimilars. Cipla Ltd is a global pharmaceutical company and owner of Cipla Medpro, South Africa’s third largest pharmaceutical manufacturer, as well as Cipla BioTec, a biotechnology company focused on affordable and accessible biopharmaceuticals.

As part of its business strategy to build a meaningful & differentiating presence in Global Oncology Therapy market, Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) today announced the roll-out of Gemcitabine InfuSMART in Europe. InfuSMART is a technology in which oncology products are developed in a Ready-To-Administer (RTA) bag.